This week, Emily and Perry take on testosterone, the raging yang to last week's sober estrogen yin. Do men actually experience "manopause" in ways similar to women? How much testosterone is not enough, what are the risks of too much, and how do you know if you need an extra boost? And what does testosterone do for men anyway? (Note: this episode on both endogenous and exogenous male sex hormones contains the existence of sex.)

Plus: the U.S. military no longer mandating the flu jab, the fishy effects of fish oil on your brain, and promising news about pancreatic cancer treatment.

Submit a question for our weekly mailbag at wellnessactually.fm.

See omnystudio.com/listener for privacy information.

This week, Emily, a woman, and Perry, a man, wade into the complicated world of hormone replacement therapy, the first of a two-part series on exogenous hormones and the sexes who love them. What do hormones do for women, and what happens when they recede? And why was HRT so closely -- and erroneously -- linked to breast cancer?

Plus: a new type of diabetes, a normie CDC director nominee, and the groovy (?) reclassification of psychedelics.

Submit a question for our weekly mailbag at wellnessactually.fm.

See omnystudio.com/listener for privacy information.

This week, Emily and Perry discuss continuous glucose monitors -- a gamechanger for diabetics and just kind of an overabundance of information for everyone else. What does glucose do to the body and what's the value of tracking it, along with everything we eat? Should we be using this data to regulate our intake? And what are the risks of knowing so much?

Plus: rising and falling birthrates, Jay Bhattacharya's politicized Covid vaccine report, and welcoming folate into our corn tortillas.

Registration link for Emily's interview with Jay Bhattacharya.

Submit a question for our weekly mailbag at wellnessactually.fm.

See omnystudio.com/listener for privacy information.